200 related articles for article (PubMed ID: 26902939)
1. Heparin-Induced Thrombocytopenia Associated with a Heparin-Bonded Stent Graft.
Blas JV; Carsten CG; Gray BH
Ann Vasc Surg; 2016 May; 33():227.e1-4. PubMed ID: 26902939
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after heparin-induced thrombocytopenia in patients with Propaten vascular grafts.
Kasirajan K
Ann Vasc Surg; 2012 Aug; 26(6):802-8. PubMed ID: 22717356
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia type II because of heparin-coated polytetrafluoroethylene graft used to bypass.
Gabrielli R; Siani A; Rosati MS; Antonelli R; Accrocca F; Giordano GA; Marcucci G
Ann Vasc Surg; 2011 Aug; 25(6):840.e9-12. PubMed ID: 21620669
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia after implantation of a heparin-bonded polytetrafluoroethylene lower extremity bypass graft: A case report and plan for management.
Thakur S; Pigott JP; Comerota AJ
J Vasc Surg; 2009 Apr; 49(4):1037-40. PubMed ID: 19341891
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Controlled Trial Comparing Crude Versus Heparin-Bonded PTFE Graft in Below the Knee Bypass Surgery for Critical Limb Ischemia (REPLACE Trial): Design and Protocol.
Gouëffic Y; Favre JP; Steinmetz E; Ordureau A; Riche VP; Guyomarch B; Rosset E
Ann Vasc Surg; 2019 Jul; 58():115-121. PubMed ID: 30769063
[TBL] [Abstract][Full Text] [Related]
6. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A
J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550
[TBL] [Abstract][Full Text] [Related]
7. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
[TBL] [Abstract][Full Text] [Related]
8. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial.
Devine C; McCollum C;
J Vasc Surg; 2004 Nov; 40(5):924-31. PubMed ID: 15557906
[TBL] [Abstract][Full Text] [Related]
9. A comparison of femorocrural bypasses performed with modified heparin-bonded expanded polytetrafluorethylene grafts and those with great saphenous vein grafts to treat critical limb ischemia.
Gessaroli M; Tarantini S; Leone M; Fabbri E; Panzini I
Ann Vasc Surg; 2015 Aug; 29(6):1255-64. PubMed ID: 26025478
[TBL] [Abstract][Full Text] [Related]
10. Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia.
Cruz D; Karlsberg R; Takano Y; Vora D; Tobis J
Catheter Cardiovasc Interv; 2003 Jan; 58(1):80-3. PubMed ID: 12508203
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia causing graft thrombosis and bowel ischemia postendovascular aneurysm repair.
Altoijry A; MacKenzie KS; Corriveau MM; Obrand DI; Abraham CZ; Steinmetz OK
J Vasc Surg; 2015 Jan; 61(1):234-6. PubMed ID: 24135622
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
13. Preservation of Heparin-Bonded Prosthetic Graft for Hemodialysis in the Setting of Early Heparin-Induced Thrombocytopenia.
Levin SR; Farber A; Siracuse JJ
Ann Vasc Surg; 2020 May; 65():282.e1-282.e3. PubMed ID: 31904512
[TBL] [Abstract][Full Text] [Related]
14. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
15. Outcome of thrombolysis and thrombectomy for thrombosed endografts inserted in the superficial femoral artery for occlusive disease.
Golchehr B; Lensvelt MM; Fritschy WM; Holewijn S; van Walraven LA; van Oostayen JA; Zeebregts CJ; Reijnen MM
J Endovasc Ther; 2013 Dec; 20(6):836-43. PubMed ID: 24325702
[TBL] [Abstract][Full Text] [Related]
16. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
[TBL] [Abstract][Full Text] [Related]
18. Heparin-related thrombosis despite normal platelet counts in vascular surgery.
Hach-Wunderle V; Kainer K; Salzmann G; Müller-Berghaus G; Pötzsch B
Am J Surg; 1997 Feb; 173(2):117-9. PubMed ID: 9074376
[TBL] [Abstract][Full Text] [Related]
19. Comparison of precuffed expanded polytetrafluorothylene and heparin-bonded polytetrafluorothylene graft in crural bypass.
Bellosta R; Natalini G; Luzzani L; Carugati C; Sarcina A
Ann Vasc Surg; 2013 Feb; 27(2):218-24. PubMed ID: 23092735
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
